Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in Mol Cell Biochem Retrieve available abstracts of 29 articles: HTML format

Single Articles

March 2022
1. ZHENG Y, Li X, Zhang F, Zhao B, et al
   Protective effect of nicorandil against myocardial ischemia/reperfusion injury mediated via IL33/ST2 signaling pathway.
   Mol Cell Biochem. 2022 Mar 28. pii: 10.1007/s11010-022-04418.
   PubMed     Abstract available
   
   
   
2. SRIVASTAVA A, Rockman-Greenberg C, Sareen N, Lionetti V, et al
   An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning beta-cell survival and cardiovascular conditions in diabetic patients.
   Mol Cell Biochem. 2022 Mar 2. pii: 10.1007/s11010-022-04396.
   PubMed     Abstract available
   
   
   February 2022
3. LIU N, Xie L, Xiao P, Chen X, et al
   Cardiac fibroblasts secrete exosome microRNA to suppress cardiomyocyte pyroptosis in myocardial ischemia/reperfusion injury.
   Mol Cell Biochem. 2022 Feb 4. pii: 10.1007/s11010-021-04343.
   PubMed     Abstract available
   
   
   
4. THAKKAR H, Vincent V, Roy A, Gautam AK, et al
   Determinants of high-density lipoprotein (HDL) functions beyond proteome in Asian Indians: exploring the fatty acid profile of HDL phospholipids.
   Mol Cell Biochem. 2022;477:559-570.
   PubMed     Abstract available
   
   
   January 2022
5. SHARMA S, Sharma U
   Exosomes in cardiovascular diseases: a blessing or a sin for the mankind.
   Mol Cell Biochem. 2022 Jan 22. pii: 10.1007/s11010-021-04328.
   PubMed     Abstract available
   
   
   
6. EYYUPKOCA F, Ercan K, Kiziltunc E, Ugurlu IB, et al
   Determination of microRNAs associated with adverse left ventricular remodeling after myocardial infarction.
   Mol Cell Biochem. 2022 Jan 20. pii: 10.1007/s11010-021-04330.
   PubMed     Abstract available
   
   
   November 2021
7. TANG XL, Wysoczynski M, Gumpert AM, Li Y, et al
   Effect of intravenous cell therapy in rats with old myocardial infarction.
   Mol Cell Biochem. 2021 Nov 16. pii: 10.1007/s11010-021-04283.
   PubMed     Abstract available
   
   
   
8. JU J, Song YN, Chen XZ, Wang T, et al
   circRNA is a potential target for cardiovascular diseases treatment.
   Mol Cell Biochem. 2021 Nov 15. pii: 10.1007/s11010-021-04286.
   PubMed     Abstract available
   
   
   October 2021
9. DONATO M, Bin EP, D Annunzio V, Gelpi RJ, et al
   Myocardial remote ischemic preconditioning: from cell biology to clinical application.
   Mol Cell Biochem. 2021;476:3857-3867.
   PubMed     Abstract available
   
   
   August 2021
10. LIU C, Yang D, Wang H, Hu S, et al
    MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease.
    Mol Cell Biochem. 2021 Aug 5. pii: 10.1007/s11010-021-04238.
    PubMed     Abstract available
    
    
    
11. YU X, Liu F, Liu Y, Bai B, et al
    Omega-3 fatty acid protects cardiomyocytes against hypoxia-induced injury through targeting MiR-210-3p/CASP8AP2 axis.
    Mol Cell Biochem. 2021;476:2999-3007.
    PubMed     Abstract available
    
    
    July 2021
12. NONG Y, Guo Y, Gumpert A, Li Q, et al
    Single dose of synthetic microRNA-199a or microRNA-149 mimic does not improve cardiac function in a murine model of myocardial infarction.
    Mol Cell Biochem. 2021 Jul 21. pii: 10.1007/s11010-021-04227.
    PubMed     Abstract available
    
    
    
13. DAS S, Mondal A, Samanta J, Chakraborty S, et al
    Unfolded protein response during cardiovascular disorders: a tilt towards pro-survival and cellular homeostasis.
    Mol Cell Biochem. 2021 Jul 14. pii: 10.1007/s11010-021-04223.
    PubMed     Abstract available
    
    
    
14. ZHANG Y, Zhao Q, Li X, Ji F, et al
    Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
    Mol Cell Biochem. 2021;476:2803-2812.
    PubMed     Abstract available
    
    
    
15. WU A, Zhang L, Chen J, Li H, et al
    Limb-bud and Heart (LBH) mediates proliferation, fibroblast-to-myofibroblast transition and EMT-like processes in cardiac fibroblasts.
    Mol Cell Biochem. 2021;476:2685-2701.
    PubMed     Abstract available
    
    
    
16. TONNESEN PT, Hjortbak MV, Lassen TR, Seefeldt JM, et al
    Myocardial salvage by succinate dehydrogenase inhibition in ischemia-reperfusion injury depends on diabetes stage in rats.
    Mol Cell Biochem. 2021;476:2675-2684.
    PubMed     Abstract available
    
    
    June 2021
17. ZHANG HA, Kitts DD
    Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases.
    Mol Cell Biochem. 2021 Jun 9. pii: 10.1007/s11010-021-04201.
    PubMed     Abstract available
    
    
    May 2021
18. SHEN W, Li H, Su H, Chen K, et al
    FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.
    Mol Cell Biochem. 2021;476:2171-2179.
    PubMed     Abstract available
    
    
    
19. NONG Y, Guo Y, Tomlin A, Zhu X, et al
    Echocardiography-guided percutaneous left ventricular intracavitary injection as a cell delivery approach in infarcted mice.
    Mol Cell Biochem. 2021;476:2135-2148.
    PubMed     Abstract available
    
    
    April 2021
20. KORE RA, Wang X, Ding Z, Griffin RJ, et al
    MSC exosome-mediated cardioprotection in ischemic mouse heart comparative proteomics of infarct and peri-infarct areas.
    Mol Cell Biochem. 2021;476:1691-1704.
    PubMed     Abstract available
    
    
    February 2021
21. ZHOU H, Liu L, Ma X, Wang J, et al
    RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage.
    Mol Cell Biochem. 2021;476:1233-1243.
    PubMed     Abstract available
    
    
    
22. LUO G, Wang R, Zhou H, Liu X, et al
    ALDOA protects cardiomyocytes against H/R-induced apoptosis and oxidative stress by regulating the VEGF/Notch 1/Jagged 1 pathway.
    Mol Cell Biochem. 2021;476:775-783.
    PubMed     Abstract available
    
    
    January 2021
23. HAN Y, Dong B, Chen M, Yao C, et al
    LncRNA H19 suppresses pyroptosis of cardiomyocytes to attenuate myocardial infarction in a PBX3/CYP1B1-dependent manner.
    Mol Cell Biochem. 2021 Jan 3. pii: 10.1007/s11010-020-03998.
    PubMed     Abstract available
    
    
    
24. MA R, Gao L, Liu Y, Du P, et al
    LncRNA TTTY15 knockdown alleviates H2O2-stimulated myocardial cell injury by regulating the miR-98-5p/CRP pathway.
    Mol Cell Biochem. 2021;476:81-92.
    PubMed     Abstract available
    
    
    November 2020
25. SHIBABAW T
    Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease.
    Mol Cell Biochem. 2020 Nov 11. pii: 10.1007/s11010-020-03965.
    PubMed     Abstract available
    
    
    October 2020
26. ZHOU W, Zheng X, Cheng C, Guo G, et al
    Rab27a deletion impairs the therapeutic potential of endothelial progenitor cells for myocardial infarction.
    Mol Cell Biochem. 2020 Oct 23. pii: 10.1007/s11010-020-03945.
    PubMed     Abstract available
    
    
    July 2020
27. ALI SR, Ahmad W, Naeem N, Salim A, et al
    Small molecule 2'-deoxycytidine differentiates human umbilical cord-derived MSCs into cardiac progenitors in vitro and their in vivo xeno-transplantation improves cardiac function.
    Mol Cell Biochem. 2020;470.
    PubMed     Abstract available
    
    
    
28. WU Y, Fan Z, Chen Z, Hu J, et al
    Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a.
    Mol Cell Biochem. 2020;470.
    PubMed     Abstract available
    
    
    May 2020
29. KOKA S, Xi L, Kukreja RC
    Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide.
    Mol Cell Biochem. 2020;468.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: